Recent chronic beryllium disease in residents surrounding a beryllium facility

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 9, 2008, Pages 1012-1017

  Maier, Lisa A ^a,b   Martyny, John W ^a   Liang, Jing ^c   Rossman, Milton D ^c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Berylliosis; Beryllium; Chronic beryllium disease; Community

Indexed keywords

METHOTREXATE; PREDNISONE; BERYLLIUM;

ADULT; AGED; ARTICLE; BERYLLIOSIS; BLOOD ANALYSIS; BLOOD CYTOLOGY; CHRONIC DISEASE; CLINICAL ARTICLE; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ENVIRONMENTAL EXPOSURE; FEMALE; GRANULOMATOUS INFLAMMATION; HUMAN; LUNG BIOPSY; LUNG GRANULOMATOSIS; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MEDICAL RECORD REVIEW; OXYGEN THERAPY; PRIORITY JOURNAL; REGISTER; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UNITED STATES; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FATALITY; FOLLOW UP; HOSPITALIZATION; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; BERYLLIOSIS; BERYLLIUM; BRONCHOALVEOLAR LAVAGE; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; ENVIRONMENTAL EXPOSURE; FATAL OUTCOME; FEMALE; FOLLOW-UP STUDIES; HUMANS; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 42949125814     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200607-1042OC     Document Type: Article

References (32)

1. Hardy HL, Tabershaw IR. Delayed chemical pneumonitis in workers exposed to berylliumcompounds. J Industr Hyg Toxicol 1946;28:197-211.
2. Van Ordstrand HS, Hughes R, DeNardi JM, Carmody MG. Beryllium poisoning. JAMA 1945;129:1084-1090.
3. Eisenbud M, Wanta RC, Dustan C, Steadman LT, Harris WB, Wolf BS. Non-occupational berylliosis. J Industr Hyg Toxicol 1949;31:281-294.
4. Hardy HL. Beryllium poisoning: lessons in control of man-made disease. N Engl J Med 1965;273:1188-1199.
5. Lieben J, Metzner F. Epidemiological findings associated with beryllium extraction. Am Industr Hyg Assoc J 1959;20:504-508.
6. Dutra FR. The pneumonitis and granulomatosis peculiar to beryllium workers. Am J Pathol 1948;24:1137-1165.
7. Sanderson WT, Petersen MR, Ward EM. Estimating historical exposures of workers in a beryllium manufacturing plant. Am J Ind Med 2001;39:145-157.
8. Shilen J, Koppenhaver F, Cleland J, Lutz L, Vought V. Beryllium extraction, reduction, and alloy fabrication. IMS Ind Med Surg 1954;23:291-299.
9. Dattoli J, Lieben J, Bisbing J. Chronic beryllium disease. J Occup Med 1964;6:189-194.
10. Lieben J, Williams RR. Respiratory diseases associated with beryllium refining and alloy fabrication: 1968 follow-up. J Occup Med 1969;9:480-485.
11. Mroz MM, Kreiss K, Lezotte DC, Campbell PA, Newman LS. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J Allergy Clin Immunol 1991;88:54-60.
12. Rossman MD. Chronic beryllium disease. In: Daniele RP, editor. Immunology and immunologic diseases of the lung. Boston, MA: Blackwell Scientific Publications; 1988. pp. 351-359.
13. Newman LS, Kreiss K, King TE Jr, Seay S, Campbell PA. Pathologic and immunologic alterations in early stages of beryllium disease: reexamination of disease definition and natural history. Am Rev Respir Dis 1989;139:1479-1486.
14. U.S. Department of Labor. Claims for compensation under the Energy Employees Occupational Illness Compensation Act. Chapter 1, Part 30. Washington, DC: U.S. Department of Labor; 2001.
15. Stange AW, Hilmas DE, Furman FJ, Gatliffe TR. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility. Appl Occup Environ Hyg 2001;16:405-417.
16. Kreiss K, Mroz MM, Zhen B, Martyny J, Newman LS. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 1993;148:985-991.
17. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med 2001;43:231-237.
18. Rossman FD, Liang J, Ming G, Maier LA. Community acquired chronic beryllium disease: a continuing problem. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:156.
19. Maier LA, Liang J, Yang G, Rossman MD. Identification of nonoccupational cases of CBD related to residence in a community surrounding a beryllium manufacturing facility [abstract]. American Public Health Association annual meeting, 2003. Available at: http://apha.confex.com/apha/131am/techprogram/ paper_74056.htm
20. Aronchick JM, Rossman MD, Miller WT. Chronic beryllium disease: diagnosis, radiographic findings, and correlation with pulmonary function tests. Radiology 1987;163:677-682.
21. Daniloff EM, Lynch DA, Bucher Bartelson B, Newell JD Jr, Bernstein SM, Newman LS. Observer variation and relationship of computed tomography to severity of beryllium disease. Am J Respir Crit Care Med 1997;155:2047-2056.
22. Newman LS, Buschman DL, Newell JD Jr, Lynch DA. Beryllium disease: assessment with CT. Radiology 1994;190:835-840.
23. Sanderson WT, Ward EM, Steenland K, Petersen MR. Lung cancer case-control study of beryllium workers. Am J Ind Med 2001;39:133-144.
24. Maier L, McGrath D, Sato H, Lympany P, Welsh K, du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, et al. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol 2003;171:6910-6918.
25. Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D. Human leukocyte antigen class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med 2002;165:788-794.
26. Sussman VH, Lieben J, Cleland JGTotal Pages: 6. An air pollution study of a community surrounding a beryllium plant. Am Industr Hyg Assoc J 1959;20:504-508.
27. U.S. Department of Energy. Federal register: chronic beryllium disease prevention program; final rule. Washington, DC: U.S. Department of Energy; 1999.
28. Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 2005;171:54-60.
29. Stange AW, Furman FJ, Hilmas DE. The beryllium lymphocyte proliferation test: relevant issues in beryllium health surveillance. Am J Ind Med 2004;46:453-462.
30. Rosenman K, Hertzberg V, Rice C, Reilly M, Aronchick J, Parker J, Regovich J, Rossman M. Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect 2005;113:1366-1372.
31. Glazer C, Barber L, Maier LA. Interstitial lung disease in a miner/recycler Available at: http://www.thoracic.org/sections/clinical- information/environmental-and-occupational/clinical-cases/pages/case7.html [Internet]. New York: American Thoracic Society; 2004.
32. Eisenbud M, Lisson J. Epidemiological aspects of beryllium-induced non-malignant lung disease: a 30-year update. J Occup Med 1983;25:196-202.